Work

Ponatinib in Chronic-Phase Chronic Myeloid Leukemia Patients: Final Report from a Phase 1 Trial

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.3063.3063

Authors: Michael J. Mauro, Jorge E. Cortes, Hagop M. Kantarjian, Neil P. Shah, Dale L. Bixby, Ian W. Flinn, Thomas O'Hare, Victor M. Rivera, Stephanie Lustgarten, Sergio Santillana, Michael C. Heinrich, Brian J. Druker, Michael W. Deininger, Moshe Talpaz

Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, University of Michigan, Sarah Cannon, Huntsman Cancer Institute, ARIAD Pharmaceuticals (United States), OHSU Knight Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603087458

FWCI: 0.264

Cites:

Cited by: 3

Related to: 10